Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score

Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B. Cornel, Sander A. Jannink, Hans de Jong, Daphne Hessels, Frank P. Smit, Willem J. G. Melchers, Gisele H. J. M. Leyten, Theo M. de Reijke, Henk Vergunst, Paul Kil, Ben C. Knipscheer, Christina A. Hulsbergen-van de Kaa, Peter F. A. Mulders, Inge M. van Oort, Wim Van Criekinge, Jack A. Schalken

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)740-748
JournalEuropean Urology
Volume70
Issue number5
DOIs
Publication statusPublished - Nov 2016

Keywords

  • Prostate neoplasms
  • Biologic markers
  • Urine
  • PSA
  • Messenger RNA
  • Logistic models

Cite this

Van Neste, L., Hendriks, R. J., Dijkstra, S., Trooskens, G., Cornel, E. B., Jannink, S. A., de Jong, H., Hessels, D., Smit, F. P., Melchers, W. J. G., Leyten, G. H. J. M., de Reijke, T. M., Vergunst, H., Kil, P., Knipscheer, B. C., Hulsbergen-van de Kaa, C. A., Mulders, P. F. A., van Oort, I. M., Van Criekinge, W., & Schalken, J. A. (2016). Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score. European Urology, 70(5), 740-748. https://doi.org/10.1016/j.eururo.2016.04.012